Ownership history in American Trust · 9 quarters on record
This page tracks every 13F SEC filing in which American Trust reported a position in RESMED INC (RMD). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 1,497 | -138 | -8.4% | 0.03% | $410K | $272.45 |
| 2025 Q2 | REDUCED | 1,635 | -1,220 | -42.7% | 0.04% | $422K | $256.26 |
| 2024 Q4 | ADDED | 2,855 | +27 | +1.0% | 0.05% | $653K | $226.15 |
| 2024 Q3 | ADDED | 2,828 | +1,354 | +91.9% | 0.06% | $690K | $240.88 |
| 2023 Q2 | ADDED | 1,474 | +295 | +25.0% | 0.02% | $322K | $212.83 |
| 2023 Q1 | REDUCED | 1,179 | -829 | -41.3% | 0.02% | $258K | $212.90 |
| 2022 Q4 | REDUCED | 2,008 | -42 | -2.0% | 0.04% | $418K | $201.95 |
| 2022 Q3 | REDUCED | 2,050 | -1,002 | -32.8% | 0.04% | $430K | $211.38 |
| 2022 Q1 | INITIATED | 3,052 | — | — | 0.05% | $740K | $233.88 |
As of 2025 Q4 — sorted by position size